Close Menu

NEW YORK – 2019 was a good year for the broader markets, and an even better year for many diagnostics companies. 

The 360Dx Index grew by more than 33 percent in 2019 compared to the previous year, outpacing the Dow Jones Industrial Average, which grew by 22 percent in 2019, and the Nasdaq Biotech Index, which increased by 24 percent. The Nasdaq Composite was up 35 percent in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.